Suv39h1 Deficiency Rescues Heart Failure 03/22/26

Welcome to Cardiology Today – Recorded March 22, 2026. This episode summarizes 5 key cardiology studies on topics like cardiac surgery and sex-based differences. Key takeaway: Suv39h1 Deficiency Rescues Heart Failure. Article Links: Article 1: Sex-Based Differences in Outcomes Following Mitral Valve Surgery: A Contemporary Analysis From 2 Institutions. (Journal of the American Heart Association) Article 2: The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension. (Cardiovascular research) Article 3: Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2. (Cardiovascular research) Article 4: Nuclear export by COPS5/CSN5/JAB1 mediates vascular smooth muscle cell dedifferentiation in neointimal hyperplasia. (Cardiovascular research) Article 5: Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation. (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/suv39h1-deficiency-rescues-heart-failure-03-22-26/ Featured Articles Article 1: Sex-Based Differences in Outcomes Following Mitral Valve Surgery: A Contemporary Analysis From 2 Institutions. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41859896 Summary: A comprehensive retrospective cohort study involving 3313 adult patients who underwent mitral valve surgery provided data to investigate sex as an independent risk factor for perioperative mortality. The analysis focused on operative mortality as the primary outcome, stratified by patient sex. This research established a foundational dataset to clarify the influence of sex on surgical outcomes in mitral valve disease. Article 2: The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41861066 Summary: S. H.) Working Group on Environment in Hypertension. A position paper by the European Society of Hypertension Working Group found that environmental pollution and climate change contribute to over 9 million premature deaths annually worldwide. Air and noise pollution demonstrate the strongest epidemiological links to hypertension and cardiovascular disease. Furthermore, emerging evidence connects light pollution, toxic metal exposure, and climate-related factors to these health burdens. This comprehensive analysis highlights the significant impact of environmental factors on global hypertension rates. Article 3: Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41861065 Summary: This study found that a deficiency in suppressor of variegation 3-9 homolog 1, or Suv39h1, attenuates cardiac fibrosis and rescues heart failure. The research demonstrated that Suv39h1 expression increased in cardiac fibroblasts during fibrosis. This mechanism was identified to operate through TACC2, suggesting a critical role for Suv39h1 in regulating cardiac extracellular matrix production. These findings reveal a novel therapeutic target for heart failure. Article 4: Nuclear export by COPS5/CSN5/JAB1 mediates vascular smooth muscle cell dedifferentiation in neointimal hyperplasia. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41861053 Summary: This study found that nuclear export mediated by COPS5/CSN5/JAB1 facilitates vascular smooth muscle cell dedifferentiation, contributing to neointimal hyperplasia. The research showed increased COPS5/CSN5 levels in human idiopathic pulmonary hypertension (I. P. A. H.) neointima, atherosclerotic lesions, and rabbit vein grafts. This suggests a direct involvement of COPS5 in vascular remodeling following injury. Understanding this mechanism offers a potential therapeutic target for conditions involving neointimal hyperplasia. Article 5: Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41854369 Summary: This study found that Lgi3 and Lgi4 proteins interact directly with K. V. 1.5 channels in human atrial tissue and heterologous cells. In a mouse model with A. A. V. 9-mediated cardiac-specific Lgi4 expression, the research observed impaired sinoatrial and atrioventricular conduction, leading to a prolonged Q. R. S. interval. The data showed delayed action potential repolarization in atria, indicating Lgi3-4 proteins modulate cardiac electrophysiology. These findings suggest Lgi3-4 proteins are potential therapeutic targets for atrial fibrillation. Transcript Today’s date is March 22, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sex-Based Differences in Outcomes Following Mitral Valve Surgery: A Contemporary Analysis From 2 Institutions. A comprehensive retrospective cohort study involving 3313 adult patients who underwent mitral valve surgery provided data to investigate sex as an independent risk factor for perioperative mortality. The analysis focused on operative mortality as the primary outcome, stratified by patient sex. This research established a foundational dataset to clarify the influence of sex on surgical outcomes in mitral valve disease. Article number two. The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (E. S. H.) Working Group on Environment in Hypertension. A position paper by the European Society of Hypertension Working Group found that environmental pollution and climate change contribute to over 9 million premature deaths annually worldwide. Air and noise pollution demonstrate the strongest epidemiological links to hypertension and cardiovascular disease. Furthermore, emerging evidence connects light pollution, toxic metal exposure, and climate-related factors to these health burdens. This comprehensive analysis highlights the significant impact of environmental factors on global hypertension rates. Article number three. Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2. This study found that a deficiency in suppressor of variegation 3-9 homolog 1, or Suv39h1, attenuates cardiac fibrosis and rescues heart failure. The research demonstrated that Suv39h1 expression increased in cardiac fibroblasts during fibrosis. This mechanism was identified to operate through TACC2, suggesting a critical role for Suv39h1 in regulating cardiac extracellular matrix production. These findings reveal a novel therapeutic target for heart failure. Article number four. Nuclear export by COPS5/CSN5/JAB1 mediates vascular smooth muscle cell dedifferentiation in neointimal hyperplasia. This study found that nuclear export mediated by COPS5/CSN5/JAB1 facilitates vascular smooth muscle cell dedifferentiation, contributing to neointimal hyperplasia. The research showed increased COPS5/CSN5 levels in human idiopathic pulmonary hypertension (I. P. A. H.) neointima, atherosclerotic lesions, and rabbit vein grafts. This suggests a direct involvement of COPS5 in vascular remodeling following injury. Understanding this mechanism offers a potential therapeutic target for conditions involving neointimal hyperplasia. Article number five. Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation. This study found that Lgi3 and Lgi4 proteins interact directly with K. V. 1.5 channels in human atrial tissue and heterologous cells. In a mouse model with A. A. V. 9-mediated cardiac-specific Lgi4 expression, the research observed impaired sinoatrial and atrioventricular conduction, leading to a prolonged Q. R. S. interval. The data showed delayed action potential repolarization in atria, indicating Lgi3-4 proteins modulate cardiac electrophysiology. These findings suggest Lgi3-4 proteins are potential therapeutic targets for atrial fibrillation. Thank you for listening. Don’t forget to subscribe. Keywords cardiac surgery, sex-based differences, Lgi3-4 proteins, K. V. 1.5 channels, mitral valve surgery, Q. R. S. interval, cardiovascular disease, COPS5, dedifferentiation, cardiac electrophysiology, operative mortality, Suv39h1, vascular smooth muscle cell, air pollution, therapeutic target, noise pollution, TACC2, patient outcomes, environmental pollution, climate change, atrial fibrillation, hypertension, vascular injury, neointimal hyperplasia, heart failure, cardiac fibrosis. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Suv39h1 Deficiency Rescues Heart Failure 03/22/26 first appeared on Cardiology Today.